 Iloprost increased permeability skeletal muscle ischemia reperfusion vascular permeability early sensitive indicator ischemic muscle injury significant histologic radionuclide changes evident effect iloprost stable prostacyclin analog microvascular permeability rat muscle model control experimental animals cremaster muscle closed-flow acrylic chamber bicarbonate buffer solution Dextran fluorescein macromolecular tracer microvascular permeability basis clearance fluorescent tracer hours ischemia hours reperfusion experimental group iloprost microgram/kg/min continuous intravenous infusion Microvascular permeability reperfusion control experimental animals Treatment iloprost response control group versus microliters/gm/min Iloprost rise vascular permeability ischemia reperfusion Experimental clinical use iloprost controlled conditions treatment patients acute skeletal muscle ischemia justified